4//SEC Filing
SLONIN JONATHAN 4
Accession 0001396814-25-000007
CIK 0001396814other
Filed
Jan 5, 7:00 PM ET
Accepted
Jan 6, 6:23 PM ET
Size
6.9 KB
Accession
0001396814-25-000007
Insider Transaction Report
Form 4
SLONIN JONATHAN
Chief Medical Officer
Transactions
- Sale
Common Stock
2025-01-06$18.40/sh−879$16,174→ 93,443.511 total - Tax Payment
Common Stock
2025-01-02$18.33/sh−371$6,800→ 94,322.511 total
Footnotes (3)
- [F1]Represents shares sold by the reporting person to cover tax obligations upon the vesting of restricted stock units.
- [F2]Includes 386.765 shares of common stock acquired under the issuer's employee stock purchase plan in December 2024.
- [F3]The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934.
Documents
Issuer
Pacira BioSciences, Inc.
CIK 0001396814
Entity typeother
Related Parties
1- filerCIK 0001875723
Filing Metadata
- Form type
- 4
- Filed
- Jan 5, 7:00 PM ET
- Accepted
- Jan 6, 6:23 PM ET
- Size
- 6.9 KB